Addition of bevacizumab or sunitinib to biweekly cetuximab and irinotecan as salvage therapy in patients with metastatic colorectal cancer after failure to CetIri

Per Pfeiffer, Trine Lembrecht Jørgensen, Benny Vittrup Jensen, Camilla Qvortrup, K Skougaard, Jon Kroll Bjerregaard, Tine Plato Hansen, Estrid Høgdal, Dorte Nielsen

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearch

Original languageEnglish
Publication date2009
Publication statusPublished - 2009
Event2009 ASCO Annual Meeting - Orlando, United States
Duration: 29. May 20092. Jun 2009

Conference

Conference2009 ASCO Annual Meeting
CountryUnited States
CityOrlando
Period29/05/200902/06/2009

Cite this